Press Releases
NBE-Therapeutics Announces Successful Validation of its SMAC™-Technology for the Generation of Antibody Drug Conjugates (ADCs)
Basel, Switzerland, February 21, 2014 - NBE-Therapeutics (“NBE”) today announced that it has presented the successful validation of its enzymatic SMAC™-Technology for the generation...
News
Roche Signs Licensing Agreement with Sysmex Inostics GmbH for emPCR Patent Portfolio
Pleasanton, CA, USA, 21 February 2014 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a licensing agreement with Sysmex Inostics GmbH for its...
News
Nuevolution Announces License Agreement with Merck
Copenhagen, Denmark, February 21, 2014 - Today announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc.,...
News
Ferrer to develop Lorediplon for insomnia with Ildong Pharmaceuticals and Ergomed Clinical Research
A Phase IIa clinical study will test the efficacy, safety and tolerability profile Ferrer, a privately-held Spanish pharmaceutical company,...
Industry Reports
Adocia: annual revenue of EUR 5.6 M in 2013
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic molecules, in particular proteins and oncologic drugs, announces...
Press Releases
Domain Therapeutics enters into collaboration with XOMA
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February 4, 2014 – Domain Therapeutics, a biopharmaceutical company specializing...
Press Releases
Cellectis grants genOway an exclusive sublicense for its homologous recombination technology in the field of genetically modified rodent models
The agreement covers the creation and sale of rodent animal models, the sale of existing rodent animal models and sublicensing rightsParis, France, February 4,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read